MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Delcath Systems ROA Ratio 2011-2026 | DCTH
Annual ROA Ratio Delcath Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.18 | -34.45 | -123.48 | -204.39 | -77.43 | -69.74 | -62.48 | -280.86 | -507.67 | -51.0 | -93.46 | -73.14 | -81.74 | -170.23 | -87.66 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.18 | -507.67 | -127.7 |
Quarterly ROA Ratio Delcath Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.08 | 15.3 | -27.53 | -65.41 | -108.17 | -156.8 | -150.5 | -106.38 | -150.27 | -151.4 | -165.42 | -125.06 | -145.76 | -122.57 | -100.15 | -67.38 | -81.79 | -75.51 | -62.04 | -49.45 | -102.36 | -140.85 | -170.44 | -150.38 | -280.13 | -356.97 | -412.32 | -122.05 | -338.61 | -350.6 | -275.18 | -507.67 | -315.19 | -176.31 | -173.36 | -50.99 | -59.3 | -71.84 | -76.43 | -93.46 | -73.47 | -77.25 | -73.1 | -73.14 | -73.66 | -73.91 | -69.33 | -81.75 | -103.8 | -123.14 | -155.98 | -170.21 | -178.57 | -163.38 | -131.25 | -87.64 | -23.58 | -15.49 | -5.24 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 15.3 | -507.67 | -133.3 |
ROA Ratio of other stocks in the Medical devices industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
-8.34 | - | - | $ 1.77 B |  USA |
 |
Lianluo Smart Limited
LLIT
|
-53.6 | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
-9.84 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-116.17 | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
-36.14 | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-18.12 | $ 10.23 | -0.97 % | $ 1.54 B | USA |
 |
EDAP TMS S.A.
EDAP
|
0.91 | $ 3.45 | 3.29 % | $ 129 M |  France |
 |
Aziyo Biologics
AZYO
|
85.61 | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
-133.04 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-9.05 | - | - | $ 3.31 B | USA |
 |
BioSig Technologies
BSGM
|
-246.76 | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-58.78 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-53.67 | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-26.13 | $ 11.1 | -0.72 % | $ 314 M | USA |
 |
Cardiovascular Systems
CSII
|
-11.45 | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
-2.11 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-323.35 | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-18.56 | $ 0.61 | -2.42 % | $ 38 M | USA |
 |
Soliton, Inc.
SOLY
|
-43.02 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-86.69 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-17.05 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-8.55 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-37.58 | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
-70.61 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-119.24 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
14.01 | $ 25.81 | 0.98 % | $ 218 M | USA |
 |
Butterfly Network
BFLY
|
-28.31 | $ 4.82 | -0.52 % | $ 1.02 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-31.81 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
-67.55 | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-128.11 | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
10.14 | $ 90.03 | -0.63 % | $ 12.2 B | USA |
 |
Helius Medical Technologies
HSDT
|
-115.05 | $ 2.16 | - | $ 1.31 M | USA |
 |
CONMED Corporation
CNMD
|
2.02 | $ 36.64 | 2.12 % | $ 1.14 B | USA |
 |
Inspire Medical Systems
INSP
|
16.03 | $ 48.25 | -12.02 % | $ 1.42 B | USA |
 |
IRIDEX Corporation
IRIX
|
-15.22 | $ 1.05 | -3.23 % | $ 17.8 M | USA |
 |
Integer Holdings Corporation
ITGR
|
3.01 | $ 85.85 | 2.26 % | $ 2.98 B | USA |
 |
Invacare Corporation
IVC
|
-2.67 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
7.84 | $ 82.91 | -0.5 % | $ 48.5 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-7.8 | $ 17.04 | 7.98 % | $ 400 M | USA |
 |
LivaNova PLC
LIVN
|
-9.3 | $ 57.59 | -2.51 % | $ 3.14 B |  Britain |
 |
LENSAR
LNSR
|
-47.99 | $ 5.48 | -1.44 % | $ 65.5 M | USA |
 |
Pulmonx Corporation
LUNG
|
-41.77 | $ 1.27 | -4.51 % | $ 51.7 M | USA |
 |
MiMedx Group
MDXG
|
14.18 | $ 3.64 | 0.83 % | $ 538 M | USA |
 |
Cutera
CUTR
|
-16.53 | - | -10.19 % | $ 1.99 M | USA |
 |
Myomo
MYO
|
-40.31 | $ 0.88 | 1.69 % | $ 36.8 M | USA |
 |
NanoVibronix
NAOV
|
-44.22 | - | - | $ 1.08 M | USA |
 |
NuVasive
NUVA
|
1.82 | - | - | $ 2.07 B | USA |
 |
Natus Medical Incorporated
NTUS
|
2.34 | - | 1.94 % | $ 1.05 B | USA |
 |
Vivos Therapeutics
VVOS
|
-84.17 | $ 0.71 | -4.7 % | $ 7.29 M | USA |